妊娠期糖耐量受损与妊娠结局的关系

①目的　探讨妊娠期糖耐量受损 (GIGT)对妊娠结局的影响。②方法　以妊娠期GIGT孕妇 1 31例(GIGT组 ) ,妊娠期糖尿病 (GDM)孕妇 1 6 6例 (GDM组 ) ,糖耐量正常孕妇 1 6 0例 (正常对照组 )为研究对象 ,对孕妇及其围生儿结局进行对比研究。③结果　GIGT组及GDM组妊娠高血压综合征、巨大儿、羊水过多、胎膜早破、剖宫产及新生儿疾病发生情况均高于对照组 (χ2 =4 .0 2～ 81 .31 ,P <0 .0 5、0 .0 1 )。④结论　GIGT对妊娠可造成不同程度的危害 ,GIGT是影响孕妇及围生儿结局的重要因素。对妊娠期GIGT均应进行监测和处理     

17β-雌二醇对子宫内膜异位症患者在位子宫内膜间质细胞β-catenin mRNA和蛋白表达的影响

目的研究17β-雌二醇(17β-E2)对子宫内膜异位症(内异症)患者在位子宫内膜间质细胞β-catenin mRNA和蛋白表达的影响,探讨Wnt/β-catenin信号通路在介导雌激素促进内异症发生发展的作用。方法体外分离培养内异症患者在位子宫内膜间质细胞。用不同浓度17β-E2处理子宫内膜间质细胞48 h;此后选用10-10mol/L 17β-E2处理子宫内膜间质细胞12、24和48 h,逆转录聚合酶链反应(RT-PCR)和免疫印迹法(Western blotting)检测17β-E2处理前后子宫内膜间质细胞β-catenin mRNA和蛋白的表达水平。同法分析雌激素受体拮抗剂ICI182,780(10-6mol/L)对17β-E2促进β-catenin mRNA和蛋白表达的影响。免疫组织化学染色观察17β-E2作用后β-catenin在子宫内膜间质细胞中的定位。结果17β-E2能明显促进内异症患者在位子宫内膜间质细胞β-catenin mRNA和蛋白的表达,并呈剂量和时间依赖性,于10-10mol/L作用48 h最明显。雌激素受体拮抗剂ICI182,780能明显抑制17β-E2对子宫内膜间质细胞β-catenin mRNA和蛋白的表达。免疫组织化学染色发现17β-E2能促进β-catenin在子宫内膜间质细胞核内的表达。结论雌激素可能通过激活Wnt/β-catenin信号通路促进内异症在位子宫内膜的异位种植。     

Diet Quality Indices and Physical Activity Levels Associated with Adequacy of Gestational Weight Gain in Pregnant Women with Gestational Diabetes Mellitus

The aim of this study was to evaluate the Diet Quality Index (DQI) and the Physical Activity (PA) levels associated with adequacy of gestational weight gain in pregnant women with gestational diabetes mellitus (GDM). A total of 172 pregnant women with a single fetus and a diagnosis of GDM participated. Food intake was self-reported on the food frequency questionnaire and DQI was quantified using the index validated and revised for Brazil (DQI-R). To assess PA, the Pregnancy Physical Activity Questionnaire was administered. Gestational weight gain was classified, following the criteria of the Institute of Medicine, into adequate (AWG), insufficient (IWG), or excessive (EWG) weight gain. A multinomial logistic regression analysis was performed, with level of significance <0.05. The participants were divided into 3 groups: AWG (33.1%), IWG (27.3%), and EWG (39.5%). The analysis indicated that if the pregnant women PA fell into tertile 1 or 2, then they had a greater chance of having IWG, whereas those with the lowest scores on the DQI-R, whose PA fell into tertile 2, and pregestational obesity women had the greatest chance of having EWG. This study has shown that low PA levels may contribute towards IWG. On the other hand, a low final DQI-R score, representing inadequate food habits, low PA levels, and pregestational obesity may increase the chance of EWG in patients with GDM.     

Pregnancy: The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostol

Although it has been demonstrated that a combination of mifepristoneand a prostaglandin is an effective method of inducing abortionin early pregnancy, the optimum dose of the antigestogen isunknown. Women (n = 220) requesting abortion in early pregnancy(63 days amenorrhoea) were randomized to receive a single doseof either 600 or 200 mg mifepristone followed 48 h later bya single dose of 600 µg misoprostol by mouth. The percentageof women who had a complete abortion (93.6% confidence interval90.4–95.5%) was identical in the two groups. There wasno significant difference in the number of women who passedthe fetus within 4 h of receiving the prostaglandin (64 versus74%), the days of bleeding (14.6 ± 1.1 versus 15.3 ±0.9) nor in the onset of the next period (39.7 ± 1.3versus 36.7 ± 1.3) respectively between the groups receiving200 or 600 mg mifepristone. However, the complete abortion ratewas significantly higher in women 49 days compared to women50–63 days amenorrhoea (97.5 versus 89.1% respectively;P < 0.02). There was no difference in any of the other parametersat different weeks of gestation. We conclude: (i) that the recommendeddose of mifepristone could be reduced from 600 to 200 mg withoutloss of clinical efficacy, (ii) that the combination of mifepristoneand 600 µg misoprostol is a highly effective alternativeto vacuum aspiration for inducing abortion in women < 50days amenorrhoea and (iii) at gestation >56 days, this combinationmay result in too many incomplete abortions to be clinicallyacceptable.     

抗肌萎缩蛋白基因51号外显子的精确定位

抗肌萎缩蛋白基因是迄今发现的人类最大基因,长约2300 kb,含有75个外显子。对该巨大基因的研究是近年来医学分子生物学研究的一个热点。虽然抗肌萎缩蛋白基因HindⅢ片段排序后就知道第51号外显子位于3.lkb的第40号HlndⅢ片段中,由于抗肌萎缩蛋白基因组DNA至今未被克隆,233bP的第51号外显子在3.lkp HindⅢ片段中的部位并不知道,也不知道它两侧的DNA结构。51号外显子     

米索前列醇用于晚期妊娠引产随机对照研究

为探讨米索前列醇用于晚期妊娠引产的效果及安全性 ,采用随机对照研究的方法对 2 85例足月孕妇 (孕周 38～ 42 )进行观察研究 ,米索前列醇组 140例 ,用 2 5μg米索前列醇 (以下简称米索 )阴道后穹隆上药 ;对照组 145例 ,催产素静脉滴注引产。结果 :米索引产组 (实验组 )引产成功率 97.14% ,明显高于对照组 82 .75 % (P<0 .0 5 ) ;实验组诱导产兆时间及总产程的时间明显短于应用催产素的对照组 ,差异有统计学意义 (P<0 .0 1)。两组的胎儿、新生儿情况、产后出血、产道撕伤、产后感染均无显著性差异。结论 :2 5μg米索阴道用药用于晚期妊娠引产的方法简单、可靠、安全 ,值得推广。     

辅助生殖技术与多胎妊娠的关系及减胎术

辅助生殖技术(又称助孕技术)的发展在治疗不孕的同时导致多胎妊娠率的提高。本文阐述助孕技术与多胎妊娠的关系,以及如何通过严格控制超促排卵指征、控制移植胚胎数量、冻存胚胎、选择性单胚胎移植、减胎术的应用等方法来获得最佳妊娠率,同时降低助孕术后的多胎妊娠特别是三胎及三胎以上妊娠的发生。     

Cadmium pathways during gestation and lactation in control versus metallothoinein 1,2-knockout mice.

Effects of metallothionein (MT) on cadmium absorption and transfer pathways during gestation and lactation in mice were investigated. Female 129/SvJ metallothionein-knockout (MT1,2KO) and metallothionein-normal (MTN) mice received drinking water containing trace amounts of (109)CdCl(2) (0.15 ng Cd/ml; 0.074 micro Ci (109)Cd/ml). (109)Cd and MT in maternal, fetal, and pup tissues were measured on gestation days 7, 14, and 17 and lactation day 11. In dams, MT influenced both the amount of (109)Cd transferred from intestine into body (two- to three-fold higher in MT1,2KO than MTN dams) and tissue-specific (109)Cd distribution (higher liver/kidney ratio in MT1,2KO dams). Placental (109)Cd concentrations in MT1,2KO dams were three- and seven-fold higher on gestation days 14 and 17, respectively, than in MTN dams. Fetal (109)Cd levels were low in both mouse types, but at least 10-fold lower in MTN fetuses. MT had no effect on the amount of (109)Cd transferred to pups via milk; furthermore, 85-90% of total pup (109)Cd was recovered in gastrointestinal tracts of both types, despite high duodenal MT only in MTN pups. A relatively large percentage of milk-derived intestinal (109)Cd was transferred to other pup tissues in both MT1,2KO and MTN pups (14 and 10%, respectively). These results demonstrate that specific sequestration of cadmium by both maternal and neonatal intestinal tract does not require MT. Although MT decreased oral cadmium transfer from intestine to body tissues at low cadmium exposure levels, MT did not play a major role in restricting transfer of cadmium from dam to fetus via placenta and to neonate via milk.     

输卵管妊娠保留输卵管手术后综合疗法的宫内妊娠探讨

对输卵管妊娠52例有生育要求者，其中28例行切开输卵管壶腹部取胚胎术，10例行输卵管峡部破裂口修补术，7例行输卵管伞部成形术，5例行输卵管峡部端端吻合术，2例行输卵管子宫角部植入术。术后给MTX与中药等综合治疗2～5个月，对其中45例行输卵管通畅检查，双侧输卵管通畅4O例，通畅率为88.9％；有41例宫内妊娠，妊娠率为78.9％，另有1例再次异位妊娠。提示：对有生育要求的输卵管妊娠尽量根据输卵管的不同情况采用相应的手术方法，并应用有效的术后综合措施，对保留患者的生育功能和提高妊娠率有重要意义。     

初孕两种不同流产方式对再次妊娠的影响

目的 探讨初孕妇女药物流产和人工流产对再妊娠的影响。方法 采用回顾性调查方法对226例有药物流产史及260例有人工流产史的初孕妇女进行比较，随访其再妊娠分娩结局。结果 两种流产对新生儿是安全的，但流产造成妊娠期先兆流产、自然流产、前置胎盘发生率，药物流产组明显低于人工流产组，分娩期并发症也是药物流产组明显低于人工流产组。结论 初孕妇女药物流产后缩短阴道出血时间对再妊娠的影响比人工流产明显减小，其安全性较大，值得在临床推广应用。